Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study

por Ai, Xiaofei, Li, Bing, Xu, Zefeng, Liu, Jinqin, Qin, Tiejun, Li, Qinghua, Xiao, Zhijian
Publicado 2021

Evaluation of Reduced-Dose Decitabine and Azacitidine for Treating Myelodysplastic Syndromes: A Retrospective Study

por Hu, Naibo, Qin, Tiejun, Du, Xiaoyan, Wang, Bingyi, Wang, Xiaoyun, Xu, Zefeng, Pan, Lijuan, Qu, Shiqiang, Xiao, Zhijian
Publicado 2021

CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia

por Cui, Yajuan, Li, Bing, Gale, Robert Peter, Jiang, Qian, Xu, Zefeng, Qin, Tiejun, Zhang, Peihong, Zhang, Yue, Xiao, Zhijian
Publicado 2014

ASXL2 mutated myelodysplastic syndrome in a novel germline G6b variant

por Qu, Shiqiang, Zhang, Donglei, Xu, Zefeng, Jia, Yujiao, Qin, Tiejun, Pan, Lijuan, Cai, Wenyu, Zhang, Yudi, Gale, Robert Peter, Xiao, Zhijian
Publicado 2022

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells

por Luo, Bingqing, Dong, Fang, Qin, Tiejun, Zhang, Qingyun, Bai, Haitao, Wang, Jinhong, Jia, Yujiao, Ma, Shihui, Jiang, Erlie, Cheng, Tao, Xiao, Zhijian, Ema, Hideo
Publicado 2022

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis

por Li, Bing, Gale, Robert Peter, Xu, Zefeng, Qin, Tiejun, Song, Zhen, Zhang, Peihong, Bai, Jie, Zhang, Lei, Zhang, Yue, Liu, Jinqin, Huang, Gang, Xiao, Zhijian
Publicado 2017

Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins

por Huang, Huijun, Liu, Jinqin, Yang, Lin, Yan, Yiru, Chen, Meng, Li, Bing, Xu, Zefeng, Qin, Tiejun, Qu, Shiqiang, Wang, Liang, Huang, Gang, Chen, Yue, Xiao, Zhijian
Publicado 2023

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder

por Huang, Huijun, Zhang, Wenjun, Cai, Wenyu, Liu, Jinqin, Wang, Huijun, Qin, Tiejun, Xu, Zefeng, Li, Bing, Qu, Shiqiang, Pan, Lijuan, Huang, Gang, Gale, Robert Peter, Xiao, Zhijian
Publicado 2021

RBC distribution width predicts thrombosis risk in polycythemia vera

por Liu, Dan, Li, Bing, Xu, Zefeng, Zhang, Peihong, Qin, Tiejun, Qu, Shiqiang, Pan, Lijuan, Sun, Xiujuan, Shi, Zhongxun, Huang, Huijun, Wang, Huijun, Gale, Robert Peter, Xiao, Zhijian
Publicado 2021

Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy

por Qu, Shiqiang, Yan, Yiru, Li, Chengwen, Xu, Zefeng, Cai, Wenyu, Qin, Tiejun, Zhang, Peihong, Jia, Yujiao, Pan, Lijuan, Gao, Qingyan, Li, Bing, Liu, Jinqin, Jiao, Meng, Xiao, Zhijian
Publicado 2023

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

por Luo, Xueping, Xu, Zefeng, Li, Bing, Qin, Tiejun, Zhang, Peihong, Zhang, Hongli, Fang, Liwei, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Zhang, Yue, Huang, Gang, Peter Gale, Robert, Xiao, Zhijian
Publicado 2018

Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms

por Zhang, Yudi, Wu, Junying, Qin, Tiejun, Xu, Zefeng, Qu, Shiqiang, Pan, Lijuan, Li, Bing, Wang, Huijun, Zhang, Peihong, Yan, Xin, Gong, Jingye, Gao, Qingyan, Gale, Robert Peter, Xiao, Zhijian
Publicado 2022

Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression

por Yan, Xin, Xu, Zefeng, Zhang, Peihong, Sun, Qi, Jia, Yujiao, Qin, Tiejun, Qu, Shiqiang, Pan, Lijuan, Li, Zhanqi, Liu, Jinqin, Song, Zhen, Gao, Qingyan, Jiao, Meng, Gong, Jingye, Wang, Huijun, Li, Bing, Xiao, Zhijian
Publicado 2023

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in...

por Wang, Jingya, Ai, Xiaofei, Qin, Tiejun, Xu, Zefeng, Zhang, Yue, Liu, Jinqin, Li, Bing, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Cai, Wenyu, Ru, Kun, Jia, Yujiao, Huang, Gang, Xiao, Zhijian
Publicado 2016

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia

por Cui, Yajuan, Tong, Hongyan, Du, Xin, Li, Bing, Gale, Robert Peter, Qin, Tiejun, Liu, Jinqin, Xu, Zefeng, Zhang, Yue, Huang, Gang, Jin, Jie, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Xiao, Zhijian
Publicado 2015

A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

por Feng, Gege, Gale, Robert Peter, Cui, Wen, Cai, Wenyu, Huang, Gang, Xu, Zefeng, Qin, Tiejun, Zhang, Yue, Li, Bing, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Wang, Jingya, Cui, Yajuan, Xiao, Zhijian
Publicado 2016

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

por Wu, Junying, Zhang, Yudi, Qin, Tiejun, Xu, Zefeng, Qu, Shiqiang, Pan, Lijuan, Li, Bing, Jia, Yujiao, Li, Chengwen, Wang, Huijun, Gao, Qingyan, Cai, Wenyu, Gong, Jingye, Zhao, Songyang, Li, Fuhui, Gale, Robert Peter, Xiao, Zhijian
Publicado 2022

Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R

por Li, Bing, Liu, Jinqin, Qu, Shiqiang, Gale, Robert Peter, Song, Zhen, Xing, Ruixian, Liu, Junxia, Ren, Yansong, Xu, Zefeng, Qin, Tiejun, Zhang, Yue, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Cai, Wenyu, Zhang, Peihong, Huang, Gang, Xiao, Zhijian
Publicado 2016

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera

por Liu, Dan, Xu, Zefeng, Zhang, Peihong, Qin, Tiejun, Li, Bing, Qu, Shiqiang, Pan, Lijuan, Cai, Wenyu, Liu, Jinqin, Wang, Huijun, Sun, Qi, Sun, Xiujuan, Jiao, Meng, Gao, Qingyan, Shi, Zhongxun, Huang, Huijun, Huang, Gang, Gale, Robert Peter, Xiao, Zhijian
Publicado 2021

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms

por Shi, Zhongxun, Liu, Jinqin, Zhao, Yingying, Yang, Lin, Cai, Yanan, Zhang, Peihong, Xu, Zefeng, Qin, Tiejun, Qu, Shiqiang, Pan, Lijuan, Wu, Junying, Yan, Xin, Li, Zexing, Zhang, Wenjun, Yan, Yiru, Huang, Huijun, Huang, Gang, Li, Bing, Wu, Xudong, Xiao, Zhijian
Publicado 2022